Journal of Cancer Research and Therapeutics Close
 

Figure 3: Apoptosis of cancer cells. Cancer cells were treated, respectively, with norcantharidin (5 μg/ml), diamminedichloroplatinum (5 μg/ml), and norcantharidin (2.5 μg/ml) plus diamminedichloroplatinum (2.5 μg/ml) for 48 h. Cell apoptosis was detected by FACScan flow cytometer. The remarkable apoptosis occurred in norcantharidin plus diamminedichloroplatinum group (P < 0.05)

Figure 3: Apoptosis of cancer cells. Cancer cells were treated, respectively, with norcantharidin (5 μg/ml), diamminedichloroplatinum (5 μg/ml), and norcantharidin (2.5 μg/ml) plus diamminedichloroplatinum (2.5 μg/ml) for 48 h. Cell apoptosis was detected by FACScan flow cytometer. The remarkable apoptosis occurred in norcantharidin plus diamminedichloroplatinum group (<i>P</i> < 0.05)